Ionctura

iOnctura is a biopharmaceutical company that focuses on developing novel therapeutics to modulate immunosuppression in the tumor microenvironment. The company aims to improve current immune checkpoint therapies by developing drugs that can optimize clinical outcomes when combined with checkpoint inhibition. iOnctura has partnerships with Merck and Cancer Research Technology, which have helped esta...